Podcasts about experimental pathology

Drs. Stephen Jameson is the President of the American Association of Immunologists, and LMP Professor and Harry Kay Chairman's Fund Professor in Experimental Pathology at the University of Minnesota Twin Cities. Dr. Bonnie Dittel is the Dr. Gilbert C. White II Endowed Faculty Chair at Versiti Blood Research Institute and Editor-in-Chief of ImmunoHorizons. In this episode, they talk about the upcoming IMMUNOLOGY2025™ meeting in Honolulu, Hawaii from May 3-7, 2025. They discuss the highlights of the program, including the President's Symposium and special sessions for new members.

A recent Lancet study reveals that over one billion people worldwide are living with obesity, equating to one in eight individuals. In South Africa, where obesity is likened to a tsunami or epidemic, 43% of adults were overweight in 2022, with a significant portion of women, men, and children with weight-related issues. Professor Carel le Roux, a global authority on obesity and diabetes from South Africa, who is the Chair of Experimental Pathology at University College Dublin, told Biznews in an interview that there has been a shift in treating obesity as a disease rather than a personal failing. Regarding semaglutide drugs for the treatment of obesity, he said they are able to turn back the clock on Type 2 diabetes, but he cautions against viewing them as mere weight loss aids. “You're going to regain all that weight, probably be worse off after you have stopped the treatment than before you started,” he said. For people with obesity and diabetes, it is a lifelong treatment. Referring to the cost of obesity drug treatment in South Africa, he said the cost of the drugs will fall over time as it happened with HIV treatment.

It feels natural to hold a grudge when someone betrays you or upsets you. After all, you are the injured party, so you are entitled to hang on to that grudge -right? Maybe. However, there are excellent reasons to let go of that grudge. This episode begins with an explanation of those reasons plus an interesting quote about grudges to drives the point home. Source: Judith Kuriansky author of The Complete Idiot's Guide to a Healthy Relationship (https://amzn.to/3KQEetb) No matter how smart you are, your brain does things to trick you. For example, your brain has trouble making sense of fractions – it just does. You are usually going to be less open-minded to ideas that conflict with what you already believe even if the evidence is clear and obvious. Those are just a few examples of how your thinking gets distorted – and there are many others. Here to explain them is James Zimring, Professor of Experimental Pathology at the University of Virginia School of Medicine and author of the book Partial Truths: How Fractions Distort our Thinking (https://amzn.to/3LxUj85). We may live on the same planet as other animals, but we live in very different worlds. The world animals experience is very different than ours. Largely, it is because the way they sense their surroundings is so different than ours. There are some animals that can see things we can't. Other animals hear things or taste things we simply cannot. This is important because the more we know about all of this, the better we can understand how our own senses work. Joining me to discuss this is Jackie Higgins. She is a writer, producer and director of films about animals and she is author of a book called Sentient: How Animals Illuminate the Wonder of Our Human Senses (https://amzn.to/3OUqY9S). You may not realize this but if you struggle with your weight, it could be your allergy medicine to blame – at least partially. Research show that some common antihistamines seem to be linked to weight gain in some people. Listen to discover more. https://www.verywellhealth.com/do-antihistamines-cause-weight-gain-83094 PLEASE SUPPORT OUR SPONSORS! Indeed is offering SYSK listeners a $75 Sponsored Job Credit to get your jobs more visibility at https://Indeed.com/SOMETHING We love the Think Fast, Talk Smart podcast! https://www.gsb.stanford.edu/business-podcasts/think-fast-talk-smart-podcast NerdWallet lets you compare top travel credit cards side-by-side to maximize your spending! Compare & find smarter credit cards, savings accounts, & more https://NerdWallet.com Luckily for those of us who live with the symptoms of allergies, we can Live Claritin Clear with Claritin-D! TurboTax Experts make all your moves count — filing with 100% accuracy and getting your max refund, guaranteed! See guarantee details at https://TurboTax.com/Guarantees Dell Technologies and Intel are pushing what technology can do, so great ideas can happen! Find out how to bring your ideas to life at https://Dell.com/WelcomeToNow eBay Motors has 122 million parts for your #1 ride-or-die, to make sure it stays running smoothly. Keep your ride alive at https://eBayMotors.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today I am speaking with Dr. Jin-Xiong She about all thing NAD+, we discuss what it is, how to measure your NAD+ levels, what impact your NAD+ levels have on your health and longevity, how to optimize your NAD+ levels and so much more! Use code KAYLA to save on all NAD+ optimization products ! About Dr. Dr. Jin-Xiong She Dr. Jin-Xiong She received his college education in China and PhD degree in France.  After a short postdoctoral training at the University of Florida (UF), he was quickly promoted to Assistant Professor, Associate Professor, Full and Endowed Professor.  He served as Division Chief of Experimental Pathology and Director of Research of the UF's world-class Diabetes Center.  Dr. She was recruited in 2002 to be the Georgia Research Alliance Eminent Scholar in Genomic Medicine at the Medical College of Georgia.  He was the founding Director of the Center for Biotechnology and Genomic Medicine, Professor of the Departments of Obstetrics and Gynecology and Department of Health Technologies as well as the director of two core research facilities for Augusta University (Genomics, Proteomics & Mass Spectrometry). In his long academic career, he has authored over 400-peer reviewed papers with an H-Index of 76 and over 19,000 citations, secured over $100 million in research grants, has been invited to speak globally.  He mentored a large number of doctoral students, post-docs and faculty members. Dr. She is one of the 20 “Georgia Top Medical Researchers”.  He served as President of the Chinese Geneticists in America and President of the American Diabetes Association's council on Immunology, transplantation and Immunogenetics among other honors.  Dr. She is a serial entrepreneur and has founded or co-founded multiple companies in the US and China. He is the founder and CEO of Jinfiniti Precision Medicine, a company dedicated to optimizing healthspan through biomarker testing and precision nutraceuticals. More information can be found on Jin-Xiong She' LinkedIn Profile and Jin-Xiong She's Google Scholar Profile. Boying DunPhD, co-Founder & Chief Innovation OfficerBob ThordarsonChief Technology OfficerMichael HeckPhD, CLIA Clinical Laboratory Director

Have you ever heard of NAD? Have you ever contemplated the key to anti-aging and embracing a rejuvenated life? Well, buckle up as we embark on a captivating journey into the enthralling domain of anti-aging and the extraordinary potential of NAD with the renowned “King of NAD”, Dr. Jin-Xiong She.  Dr. Jin-Xiong She, PhD is a serial entrepreneur and founder of Jinfiniti Precision Medicine, a company dedicated to optimizing healthspan through biomarker testing and precision nutraceuticals. He received his college education in China and PhD degree in France and was quickly promoted to Endowed Professor, Chief of Experimental Pathology and Director of Diabetes Research at the University of Florida. He has had professorships in multiple universities, served in key academic leadership positions, and received prestigious awards in academic research and services. He is an eminent scholar in biotechnology, has authored over 400 scientific papers with over 20,000 citations, secured over $100 million in research grants, and invited to speak globally. He is one of the 20 “Georgia Top Medical Researchers”. He served as President of the Chinese Geneticists in America and President of the American Diabetes Association's Council on Immunology, transplantation, and Immunogenetics among other honors. He currently focuses on providing end-to-end solutions to optimize performance, health span, and lifespan via a holistic approach guided by actionable biomarkers. Join us as Dr. She reveals the groundbreaking research surrounding NAD, illuminating its pivotal role in powering cellular function and vitality. Learn how declining NAD levels impact your body and mind, and explore the transformative potential of optimizing this essential molecule for a healthier, more vibrant life. Let's dive in! In this episode, you will learn: What is NAD? Why is NAD important for overall health? Factors influencing decreased NAD levels in the body The benefits of having optimized NAD levels NAD Precursors and their role in boosting cellular health The Accuri® Vitality Boost Formula - key ingredients that fuel enhanced vitality and health Factors that influence aging The importance of balancing genetics and lifestyle for longevity Links and Resources Jinfiniti Precision Medicine - Get 20% off! Use code EMILY20 | https://www.jinfiniti.com/shop/  Enter our giveaway! DM NAD + your name, for a chance to be among three lucky listeners to receive a Jinfiniti NAD Optimization Package Connect with Dr. She On Website | https://www.jinfiniti.com/ On Instagram | https://www.instagram.com/jinxiongshe/  On LinkedIn | https://www.linkedin.com/in/jin-xiong-she-phd-311b461a7/  Connect with Emily On Website | https://www.itsemily.com/ On Instagram | https://www.instagram.com/itsemily/ On Facebook | https://www.facebook.com/itsemilymethod On Twitter | https://www.twitter.com/itsemilyford On YouTube | https://www.youtube.com/c/ITSEMILYFORD 

Dr. Mitchell Lee, Ph.D. is the Chief Executive Officer of Ora Biomedical ( https://orabiomedical.com/ ), a biotech company developing small molecule therapeutics that extend lifespan and delay chronic illness by targeting the underlying molecular mechanisms of aging. Dr. Lee's research interests are focused on identifying healthy aging therapeutics, understanding the connections between aging and age-related disease, and investigating how natural genetic variation modifies disease and therapeutics efficacy. He has earned awards for science communication, multiple NIH training grants, and in 2015 was awarded a Howard Hughes Medical Institute (HHMI) Gilliam Fellowship for Advanced Study. Dr. Lee has centered his career around leading and managing scientists. During graduate and postdoctoral studies, he mentored over 45 trainee researchers ranging from high schoolers, community college and university undergraduates, to post-baccalaureates and grad students. In recognition of his research mentorship, Dr. Lee was awarded a UW Undergraduate Research Mentor Award in 2018. Dr. Lee was the founding Chair of the American Aging Association (AGE) Trainee Chapter and served on the Executive Committee and Board of Directors for AGE. During this time, Dr. Lee established standing leadership committees, founded and managed the GeroScience Peer Review Training Program, and organized multiple research conferences. Dr. Lee received a B.S. in Biology and a B.A. in Philosophy from Western Washington University in 2010. He remained at WWU and completed an M.S. in Biology in 2012. He received his PhD in Experimental Pathology from the University of Washington School of Medicine in 2018. Most recently, Dr. Lee completed a certificate in Biotechnology Project Management from UW/UCSD in 2022. Support the show

Lucas interviews Jennifer Gu, to discuss the benefits of MagTein. Dr. Jennifer Gu is the VP of Research and Development at AIDP, Inc. She has been responsible for new product development, clinical studies and intellectual property development for AIDP since 2005. She has been actively involved in the discovery and commercialization of patented ingredients including Magtein® and KoAct®. Dr. Gu received her PhD in Experimental Pathology at the University of California, Los Angeles and completed her post-doctoral work at the California Institute of Technology in the Division of Biology. Dr. Gu published extensively in peer-reviewed journals including “Nature” during her academic life. Dr. Gu holds multiple patents and is a frequent speaker and contributor to nutritional journal articles.Relevant links:https://www.boostyourbiology.com/ Buy Magceutics here: www.magceutics.com Hosted on Acast. See acast.com/privacy for more information.

Synopsis: Andrew Scharenberg is the Co-founder and CEO of Umoja Biopharma, a company pioneering the future of immunotherapy by reprogramming T cells in vivo. Umoja's groundbreaking integrated platform therapeutics reprogram the immune system in the patient's body to target cancer cells and generate lasting remissions. Andrew talks about the CAR T-cell therapy space, the opportunities he sees, and how he sees the space evolving over the next two decades. He discusses the work that his team is pursuing at Umoja to develop a new approach to cancer therapy that retools a patient's immune system in vivo, enhancing the body's natural capacity to fight cancer, and where the company is from a development perspective. He also talks about how he thinks about indication selection, particularly in the early stages of biotech. Finally, he shares how the pandemic impacted his approach to team building and his thoughts on distributed teams. Biography: Dr. Andrew M. Scharenberg is the founder and CEO of Umoja Biopharma, an MPM portfolio company. He also serves as an Executive Partner at MPM Capital, and Chairs the Scientific Advisory Boards at Generation Bio, Genti Bio, and Alpine Immune Sciences. Prior to founding Umoja, Andrew co-directed the Program in Cell and Gene Therapy at Seattle Children's Research Institute, working to translate cell and gene therapies for the treatment of inherited immunologic and blood diseases. This work led to the development of a program in engineered regulatory T-cells, partnered with Casebia Therapeutics for the purpose of developing a gene edited cell therapeutic for Type I diabetes and other inflammatory diseases. Previously, he was the Chief Scientific Officer of Cellectis Therapeutics, where he initiated the development of an allogeneic CAR T-cell platform, and co-founder of Pregenen Inc., a gene editing and cell-signalling technology company that was acquired by bluebird bio in 2014. Andrew earned his M.D. from the University of North Carolina School of Medicine, and then completed residency at the University of North Carolina Children's Hospital and his fellowship in immunology at NIH and at the Division of Experimental Pathology, Beth Israel Hospital. From 2000 to 2020, he was an attending Physician at Seattle Children's Hospital, a Professor in the Department of Pediatrics, and an Adjunct Professor in the Department of Immunology at the University of Washington School of Medicine in Seattle. Andrew received the American Pediatric Society/Society for Pediatric Research National Young Investigator Award in 2002. He is an active member of the American Society for Clinical Investigation and the American Pediatric Society.

Magnesium L-threonate and Memory Dr. Jennifer Gu Dr. Jennifer Gu received her PhD in Experimental Pathology at the University of California, Los Angeles and completed her post-doctoral work at the California Institute of Technology in the Division of Biology. Dr. Gu published extensively in peer-reviewed journals including “Nature” during her academic life. Dr. Gu holds multiple patents and is a frequent speaker and contributor to nutritional journal articles. She is currently the VP of Research and Development at AIDP, Inc. She has been responsible for new product development, clinical studies, intellectual property development, and regulatory compliances for AIDP since 2005.

Magnesium L-threonate and Memory Compared to other forms of magnesium on the market, magnesium L-threonate is an ultra-absorbable magnesium for the brain. On this show Drs. Mike and Crystal sit down with Dr. Jennifer Gu to review the latest research on this novel form of magnesium. Dr. Jennifer Gu Dr. Jennifer Gu received her PhD in Experimental Pathology at the University of California, Los Angeles and completed her post-doctoral work at the California Institute of Technology in the Division of Biology. Dr. Gu published extensively in peer-reviewed journals including “Nature” during her academic life. Dr. Gu holds multiple patents and is a frequent speaker and contributor to nutritional journal articles. She is currently the VP of Research and Development at AIDP, Inc. She has been responsible for new product development, clinical studies, intellectual property development, and regulatory compliances for AIDP since 2005.

------------------Support the channel------------ Patreon: https://www.patreon.com/thedissenter PayPal: paypal.me/thedissenter PayPal Subscription 1 Dollar: https://tinyurl.com/yb3acuuy PayPal Subscription 3 Dollars: https://tinyurl.com/ybn6bg9l PayPal Subscription 5 Dollars: https://tinyurl.com/ycmr9gpz PayPal Subscription 10 Dollars: https://tinyurl.com/y9r3fc9m PayPal Subscription 20 Dollars: https://tinyurl.com/y95uvkao ------------------Follow me on--------------------- Twitter: https://twitter.com/TheDissenterYT This show is sponsored by Enlites, Learning & Development done differently. Check the website here: http://enlites.com/ Dr. James Zimring is Thomas W. Tillack Professor of Experimental Pathology at the University of Virginia. He is the author of What Science Is and How It Really Works (2019). His latest book is Partial Truths: How Fractions Distort Our Thinking. In this episode, we focus on Partial Truths. We start with the premise of the book, and explain what a fraction is. We go through some biases and heuristics, like the confirmation bias and the availability heuristic, and talk about their evolution. We discuss bias within the criminal justice system. We talk about finding patterns where they do not exist, as in conspiracy theories and prophecies. We discuss why the Universe appears to be designed. We talk about the bad uses of statistics in science. We discuss social cognition, and an interactionist model of human reasoning, as opposed to an intellectualist one. Finally, we ask if it would really be good to overcome errors of reasoning. -- A HUGE THANK YOU TO MY PATRONS/SUPPORTERS: KARIN LIETZCKE, ANN BLANCHETTE, PER HELGE LARSEN, LAU GUERREIRO, JERRY MULLER, HANS FREDRIK SUNDE, BERNARDO SEIXAS, HERBERT GINTIS, RUTGER VOS, RICARDO VLADIMIRO, CRAIG HEALY, OLAF ALEX, PHILIP KURIAN, JONATHAN VISSER, JAKOB KLINKBY, ADAM KESSEL, MATTHEW WHITINGBIRD, ARNAUD WOLFF, TIM HOLLOSY, HENRIK AHLENIUS, JOHN CONNORS, PAULINA BARREN, FILIP FORS CONNOLLY, DAN DEMETRIOU, ROBERT WINDHAGER, RUI INACIO, ARTHUR KOH, ZOOP, MARCO NEVES, COLIN HOLBROOK, SUSAN PINKER, PABLO SANTURBANO, SIMON COLUMBUS, PHIL KAVANAGH, JORGE ESPINHA, CORY CLARK, MARK BLYTH, ROBERTO INGUANZO, MIKKEL STORMYR, ERIC NEURMANN, SAMUEL ANDREEFF, FRANCIS FORDE, TIAGO NUNES, BERNARD HUGUENEY, ALEXANDER DANNBAUER, FERGAL CUSSEN, YEVHEN BODRENKO, HAL HERZOG, NUNO MACHADO, DON ROSS, JONATHAN LEIBRANT, JOÃO LINHARES, OZLEM BULUT, NATHAN NGUYEN, STANTON T, SAMUEL CORREA, ERIK HAINES, MARK SMITH, J.W., JOÃO EIRA, TOM HUMMEL, SARDUS FRANCE, DAVID SLOAN WILSON, YACILA DEZA-ARAUJO, IDAN SOLON, ROMAIN ROCH, DMITRY GRIGORYEV, TOM ROTH, DIEGO LONDOÑO CORREA, YANICK PUNTER, ADANER USMANI, CHARLOTTE BLEASE, NICOLE BARBARO, ADAM HUNT, PAWEL OSTASZEWSKI, AL ORTIZ, NELLEKE BAK, KATHRINE AND PATRICK TOBIN, GUY MADISON, GARY G HELLMANN, SAIMA AFZAL, ADRIAN JAEGGI, NICK GOLDEN, PAULO TOLENTINO, JOÃO BARBOSA, JULIAN PRICE, EDWARD HALL, HEDIN BRØNNER, DOUGLAS P. FRY, FRANCA BORTOLOTTI, GABRIEL PONS CORTÈS, URSULA LITZCKE, DENISE COOK, SCOTT, ZACHARY FISH, TIM DUFFY, TRADERINNYC, TODD SHACKELFORD, AND SUNNY SMITH! A SPECIAL THANKS TO MY PRODUCERS, YZAR WEHBE, JIM FRANK, ŁUKASZ STAFINIAK, IAN GILLIGAN, LUIS CAYETANO, TOM VANEGDOM, CURTIS DIXON, BENEDIKT MUELLER, VEGA GIDEY, THOMAS TRUMBLE, AND NUNO ELDER! AND TO MY EXECUTIVE PRODUCERS, MICHAL RUSIECKI, ROSEY, JAMES PRATT, MATTHEW LAVENDER, SERGIU CODREANU, AND BOGDAN KANIVETS!

Regenerative Medicine Today welcomes Dr. Mo Ebrahimkhani.  Dr. Ebrahimkhani is an Associate Professor in the Department of Pathology, School of Medicine, University of Pittsburgh.  He is also a member of the Division of Experimental Pathology and the Pittsburgh Liver Research Center. Dr. Ebrahimkhani discusses his research in systems and synthetic biology-based approaches to [...]

It's a Rutgers reunion y'all! In this episode, Fatu and Shekerah reconnect with another Rutgers alum–Joseph Iacona, who is a Scientist in Experimental Pathology at Janssen. As a scientist, Joey applies molecular techniques to assist in the drug development process.  Essentially, he works in the early phase of drug development at the intersection of discovery and non-clinical safety, where his discoveries can influence the course of drug design. Joey's work expands across many different disease areas and projects throughout the company, which adds a lot of variety and dynamism to his work. Additionally, Joey discusses the differences he's experienced working in industry compared to academia including the role that curiosity plays in each setting. Joey's journey in transitioning to industry was influenced by experiences he had as part of the Rutgers iJOBS program (another Rutgers shout-out!), which examines career opportunities for biomedical graduate students and postdocs. Overall, the journey into industry has been a positive transition from academia for Joey; his role offers lots of diversity in the projects he gets to work on and a very collaborative environment working within and across teams to develop new treatments for diseases. Reach out to Joey: https://www.linkedin.com/in/josephiacona77 Reach out to Fatu: https://www.linkedin.com/in/fatubmTwitter: @fatu_bm and LoveSciencePodcast@gmail.comReach out to Shekerah: www.linkedin.com/in/shekerah-primus and LoveSciencePodcast@gmail.comMusic by TimMoor from Pixabay: Future Artificial Intelligence Technology 130Music by ScottHolmesMusic https://freemusicarchive.org/music/Scott_Holmes: Hotshot

Fractions can be confusing – and that's not great news for communicators. James C. Zimring, Thomas W. Tillack Professor of Experimental Pathology at the University of Virginia School of Medicine, joins host Krys Boyd to discuss percentages, probabilities, and the other data that can confound and even deceive us – and how to not fall into familiar, time-worn traps. His book is “Partial Truths: How Fractions Distort Our Thinking.” This episode originally aired on July 19, 2022.

On this edition of Parallax Views, James C. Zimring, M.D., Ph.D., Thomas W. Tillack Professor of Experimental Pathology at the University of Virginia, joins us to discuss his new book Partial Truths: How Fractions Distort Our Thinking. Zimring is also the author of What Science Is and How It Really Works. This conversation was recorded on 6/21/22. In this conversation Zimring explains what his book is about and how it deals with the ways in which fractional thinking shapes the way we think about the world. When we talk about fractions and fractional thinking in this conversation, however, we are not talking about solving math problems in an classroom or academic setting. Instead, as Zimring explains, we discussing our everyday usage of fractional thinking that we often take for granted. This fractional thinking is necessary, as we learn in this conversation, but also can distort our perception about a number of phenomena and issues. Among the topics covered in this conversation are: - Fractional thinking and the moral panic around Dungeons and Dragons in the 1980s - Fractional thinking and the blunder of the Iraq War during the Presidency of George W. Bush - Fractional thinking and the strange story of a McDonald's burger - New Age beliefs, spirituality, religion, and an on-air cold reading experiment - Heuristics, the availability heuristic, and inductive reasoning - A recent study by the Heritage Institute on Israel and China and the fault reasoning used in the study - Big data and racism - Information, p-hacking, selective reporting, and faulty academic studies - The problems of science reporting - And much, much more!

Ria Lina is a touring Filipina comedian, actress and writer known for her appearances on BBC's Live At The Apollo, Have I Got News For You, The Now Show and Mock The Week - and in November was named as one of The Evening Standard's ‘Hottest Comedians You Should Be Watching Now'. Throughout her stand-up career Ria has taken five shows to the Edinburgh Fringe Festival with her work tackling topics such as autism, topical news and racial identity. Her career stretches from stage and screen, to radio and the occasional ukulele - all in a unique style described by ‘The Scotsman' as ‘fearless , provocative and very funny'.Ria is the only Filipina comedian in British stand up and has a BSc in Experimental Pathology, an MSc in Forensic Science and a PhD in Virology under her belt, so it's not only Ria's comedy that's highly intelligent. A regular pundit on Sky News, BBC News, Times Radio and TalkRadio, Ria is in demand for both her scientific insight, confident delivery and biting wit.A prolific writer, Ria has written for the Ladyboys of Bangkok ‘Fantasy & Feathers' and ‘Glamorous Amorous' tours, and wrote and acted in ITV2 comedy sketch show ‘Meet the Blogs'. She has also written and presented her own Channel 4 documentary that revealed the truth behind the myths that surround East Asian women in Britain.‘Fearless, provocative and very funny'Scotsman‘Engaging, endearing and eye-opening'Time Out‘She's like a Filipina Sarah Silverman'Dusty LimitsThanks for watching! Like, subscribe, drop a comment, all the good stuff.Subscribe to Patreon for early access to episodes PLUS a bonus solo episode every week

Host Dave Schlom visits with James Zimring, Professor of Experimental Pathology at the University of Virginia.

Holding on to a grudge can feel righteous. After all, you've been wronged. You are entitled to hold that grudge. However, there are a lot more reasons - and better ones - to let that grudge go. This episode begins with an explanation and a great quote to remember about grudges. Source: Judith Kuriansky author of The Complete Idiot's Guide to a Healthy Relationship (https://amzn.to/3KQEetb) So many things can alter your thinking in ways you don't realize. For example, the human brain has trouble making sense of fractions. We are also less open minded to ideas that conflict with what we already believe even if the evidence is obvious. And there are other ways your thinking gets distorted. Joining me to discuss this is James Zimring, Professor of Experimental Pathology at the University of Virginia School of Medicine and author of the book Partial Truths: How Fractions Distort our Thinking (https://amzn.to/3LxUj85). The world animals live in is very different than ours. Mainly, that's because the way they sense their surroundings is so much different. Some animals see what we can't, others hear what we can't while others taste what we can't. And the more we know about this, the better we can understand our own senses. Listen as my guest Jackie Higgins explains. Jackie is a writer, producer and director of films about animals and she is author of a book called Sentient: How Animals Illuminate the Wonder of Our Human Senses (https://amzn.to/3OUqY9S). If you struggle with your weight, your allergy medicine may be partially to blame. Some common antihistamines have been linked to weight gain in some people. Listen as I explain what the research says. https://www.verywellhealth.com/do-antihistamines-cause-weight-gain-83094 PLEASE SUPPORT OUR SPONSORS! Go to https://Indeed.com/Something to claim your sponsored job $75 credit to upgrade your job post! Offer good for a limited time. With Avast One, https://avast.com you can confidently take control of your online world without worrying about viruses, phishing attacks, ransomware, hacking attempts, & other cybercrimes! With prices soaring at the pump, Discover has your back with cash back! Use the Discover Card & earn 5% cash back at Gas Stations and Target, now through June, when you activate. Get up to $75 cash back this quarter with Discover it® card. Learn more at https://discover.com/rewards Small Businesses are ready to thrive again and looking for resources to rise to the challenge. That's why Dell Technologies has assembled an all-star lineup of podcasters (and we're one of them!) for the third year in a row to create a virtual conference to share advice and inspiration for Small Businesses. Search Dell Technologies Small Business Podference on Audacy.com, Spotify or Apple podcasts starting May 10th! Today is made for Thrill! Style, Power, Discovery, Adventure, however you do thrill, Nissan has a vehicle to make it happen at https://nissanusa.com Use SheetzGo on the Sheetz app! Just open the app, scan your snacks, tap your payment method and go!  Learn more about your ad choices. Visit megaphone.fm/adchoices

Across the first 2 episodes of Unlearn to Learn, we were joined by healthcare professionals from the US and Canada. In this episode, we shift the format slightly, to a discussion between a specialist and a patient, to hear how the treatment of obesity impacts on mental wellbeing. We'll be joined by Professor Carel Le Roux from the University College Dublin, and Wendy Reaser, a patient living with obesity from Saskatchewan, Canada. Carel is Director of the Metabolic Medicine Group. He obtained his PhD from Imperial College London, and then moved to University College Dublin as Chair in Experimental Pathology.

The LabOpp Global Leaders podcast is a series of conversations about Careers, the Lab Industry, Training, and People. In this episode, we asked Ahneez Abdul Hameed, a dynamic clinical microbiologist, to interview a close friend and colleague Subasri Armon. Subasri has been making her way through the molecular pathology field and taken on many varied responsibilities including responsibilities in cancer research, and biobanking. Amongst many other topics, she shares her views on the varied roles of molecular pathology on the future of medicine. If you would like to get in touch with Subasri, you can find her on LinkedIn Some of the organizations mentioned during this podcast: Manipal University College Malaysia https://manipal.edu.my/ Universiti Putra Malaysia https://upm.edu.my/ Laboratory of Clinical and Experimental Pathology, Nice University Hospital, University Cote d'Azur, Nice, France https://www.chu-nice.fr/nos-hopitaux/hopital-pasteur http://www.biobank-cotedazur.fr/ International Agency for Research on Cancer (Evidence Synthesis and Classification Branch & Laboratory Services and Biobank Group), W.H.O., Lyon, France https://www.iarc.who.int/ Biological Resource Center (PGEM) & Molecular Laboratory, Centre Leon Berard, Lyon, France https://www.centreleonberard.fr/en Molecular Pathology Unit, Institute for Medical Research, National Institute of Health, Malaysia https://www.nih.gov.my/ If you have suggestions for future guests or comments about this podcast, please visit us at labopp.org/podcast --- Send in a voice message: https://podcasters.spotify.com/pod/show/labopp/message

The realm of advanced technology sounds like something coming out of a sci-fi movie but the future's real and it's here! This is the advocacy of our guest, Kim Solez. As much as we want to entrust humans in solving big problems, we must learn how to utilize our available tech to make our lives better. He obtained his M.D. with AOA honours from the University of Rochester School of Medicine and Dentistry, and trained in pathology at Johns Hopkins Medical Institutions in Baltimore, Maryland. He joined the faculty at Johns Hopkins and in 1987 became chairman of the Department of Pathology at the University of Alberta in Edmonton, Canada. In 1991, he established the Banff Classification, the first standardized, international classification for renal allograft biopsies, with Johns Hopkins pathologist Lorraine Racusen. As chair of the International Society of Nephrology (ISN) Commission on Acute Renal Failure, from 1989 to 1997, Solez started the ISN Disaster Relief Task Force, a worldwide network of experts working closely with Médecins Sans Frontières. In 1997, Solez worked to end the mysterious Haitian diethylene glycol poisonings. In 2002, Solez founded Leonard Cohen Night, celebrating the work of Canadian singer-songwriter Leonard Cohen. In 2010, Solez completed the Singularity University Executive Course, and in 2011 pioneered a unique graduate level medical course Technology and the Future of Medicine at the University of Alberta. Solez has led the University of Alberta's involvement in the creation and further development of a unique medical school in Nepal devoted to rural health Patan Academy of Health Sciences. Solez continues work as a Pathologist at the University of Alberta, as well as Professor and Director of Experimental Pathology in the Department of Laboratory Medicine and Pathology.In this episode, Kim highlights the impact of technology not just to make our lives convenient but also to solve big issues of humanity. More than ever, we are living in a world of opportunity and it's just a matter of time for us to realize the need for these tools. Join us and listen in![00:01 - 08:02] Opening Segment Welcoming Kim to the showReimagining artificial intelligence as a problem-solving tool[08:03 - 16:59] Utilizing AI to Solve the Biggest Threats in HumanityFacing inaccurate depictions of AIFinland's initiative to incorporate artificial intelligence[17:00 - 36:34] Embracing Diversity to the Advocacy of ReformationWorking on big ideas with diverse personalitiesChallenges to keeping the momentum of the advocacy[36:35 - 46:12] Closing SegmentDo not just conform - lead life without precedentConnect with Kim!Closing wordsTweetable Quote:“Leading a life without precedent, doing something no one's done before is actually easier than following an existing path. Because nobody has any way to measure how well you're doing. Nobody's ever done it before. " - Kim SolezConnect with Kim:Instagram: https://www.instagram.com/kimsolez/YouTube: https://www.youtube.com/user/KimSolezWikipedia: https://en.wikipedia.org/wiki/Kim_Solez LEAVE A REVIEW + help someone who wants to explode their business growth by sharing this episode or click here to listen to our previous episodes.Dreamcatchers is an inclusive organization that targets people's interest in being more instead of a certain demographic. We have people from all walks of life at many different ages. Find out more at www.dreamsshouldbereal.com. Find out more about Jerome at www.d3v3loping.com or www.myersmethods.com.

In this episode I am joined by the irrepressible Ria Lina. As well as being a top notch comedian, Ria has a BSc in Experimental Pathology, an MSc in Forensic Science and a PhD in Virology. More degrees that you can shake a Polaroid picture at. She's a fab talker and our conversation covered more miles than Ellen MacArthur. From breastfeeding to the civil service to gender to the British education system to how they treat public servants in Singapore. And more. Enjoy. More about Ria: Ria is a comedian, writer and actor who has been seen on on shows like Mock The Week (BBC), Yesterday, Today and the Day Before (Comedy Central) and Unforgivable (Dave). At the time of publishing, she's the only pro Filipino comedian in the UK today and probably the only one with all those tasty degrees but that makes for an intelligent, considered and vital comedian and comedy writer. She's got various scripted projects up her sleeve as well as more TV appearances to come. Keep up by following Ria on her socials: Twitter: @rialina_ Instagram: @rialina_      

Professor le Roux is an expert in metabolic medicine and is currently a Professor of Experimental Pathology, University College Dublin. He is recognised as a world leader in metabolism and obesity. Professor le Roux's clinical focus is in the management of Type 2 diabetes, pre-diabetes, obesity, cardiovascular risk and other metabolic disorders. Professor Carel le Roux has been published extensively and currently holds a number of editorial roles for journals in his field including, Clinical Obesity and Surgery for Obesity and Related Diseases. Show notes are available at: sigmanutrition.com/episode395

The GLP-1 receptor agonist class offers multifactorial benefits, including reductions in blood glucose, weight loss and cardiovascular protection. But do these vary across the class, and which patients should be offered one? And given they also carry a high risk of gastrointestinal side effects, how should we approach initiating therapy? Join us for a conversation with Prof. Carel Le Roux, Professor of Experimental Pathology and Co-Director of the Metabolic Medicine Group at University College Dublin, and Reader in Investigative Science at Imperial College London. For more free education, visit the DKIP website, follow us on Twitter (@dkipractice) or connect on LinkedIn. Disclosures: Professor Carel Le Roux has been an advisory board member for Boehringer Ingelheim, Herbalife, GI Dynamics, Johnson & Johnson, and Novo Nordisk. References: Trujillo J et al. Ther Adv Endocrinol Metab. 2021 Mar;12 American Diabetes Association. Diabetes Care 2021; 44(Supplement 1) Buse J et al. Diabetes Care. 2020 Feb;43(2):487-493 Marso S et al. N Engl J Med. 2016 Jul 28;375(4):311-22 [LEADER] Marso S et al. N Engl J Med. 2016 Nov 10;375(19):1834-1844 [SUSTAIN 6] Hernandez A et al. Lancet. 2018 Oct 27;392(10157):1519-1529 [Harmony Outcomes] Gerstein H et al. Lancet. 2019 Jul 13;394(10193):121-130 [REWIND] Husain M et al. N Engl J Med. 2019 Aug 29;381(9):841-851 [PIONEER 6] Funding statement: This independent educational activity is supported by an educational grant from Eli Lilly, Merck Sharp and Dohme Corp. and Novo Nordisk A/S. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; the financial supporters have had no influence on the content of this education.

MENTAL HEALTH AWARENESS SPECIAL From being diagnosed with Bipolar disorder to successfully defending her thesis during a global pandemic, Kimberly Fiock (Feeock) has set an example for what’s possible when you find ways to manage your mental health. Kimberly has a Bachelor of Science in Neuroscience and Psychology from UT Dallas and a Master of Science in Pathology from the University of Iowa. She is currently pursing PhD in Experimental Pathology at the University of Iowa. She works as a graduate assistant for the Iowa NeuroBank Core, a brain tissue and stem cell repository at the University of Iowa. She also serves as a Court Appointed Special Advocate, where she advocates and supports abused and neglected children as they navigate the foster care system.  She runs an interesting IG account called thepathphd to talk all things pathology and mental health.  In this episode, we will discuss Kimberly’s STEM story and how she thinks we can improve and manage our mental health in STEM.

Making virus testing easy, or at least easier, will enable companies and organizations to reopen faster as we enter the beginning of the post-corona era. Dr. Timothy Garrett, the Chief of Experimental Pathology at the University of Florida, has developed a test that can detect multiple viruses, including variants, from a single sample. Better yet, this can be done in a portable lab for remote testing, potentially making it widely available in many communities. TRANSCRIPT: Intro: 0:01 Inventors and their inventions. Welcome to Radio Cade and podcast from the Cade Museum for Creativity and Invention in Gainesville, Florida. The museum is named after James Robert Cade, who invented Gatorade in 1965. My name is Richard Miles. We’ll introduce you to inventors and the things that motivate them, we’ll learn about their personal stories, how their inventions work and how their ideas get from the laboratory to the marketplace. Richard Miles : 0:39 Making virus testing easy, or at least easier will enable companies and organizations to reopen faster. As we enter the beginning of the post Corona era. Welcome to Radio Cade. I’m your host, Richard Miles. And today I’m pleased to welcome Dr. Timothy Garrett an Associate Professor and the Chief of Experimental Pathology at the University of Florida, as well as the founder of three companies, including Juno Metabolomics where he remains the Chief Scientific Officer. And he’s also a friend. So welcome to Radio Cade Tim . Dr. Timothy Garrett: 1:06 I’m glad to be here. Thanks. Richard Miles : 1:07 So Tim, I usually save the toughest question for last, but I’m going to cut straight to the chase. How does a guy who did his undergrad, the University of Georgia and up at the University of Florida? Cause I thought we had rules preventing that from happening. Dr. Timothy Garrett: 1:18 There are a lot of social roles involved in that. But the short answer is that at the University of Georgia, I got introduced to a technique that allowed me the new area of study. And when I came to Florida and one of the top people in my field was here. And so I decided once I got in and this was a great place to go and we liked the warm weather and living in Florida, was attracted to that. So somehow they let a Georgia bulldog and to the University of Florida. And now I guess you can call me a true bull gator because I am a bulldog and a gator. Richard Miles : 1:46 Well, I hope I haven’t blown your secret and they rescind your tenure or something. Anyway, we’ll talk a little bit about your background later, but let’s start out by talking about what it is that you have actually developed and why we invited you on the show. And so you’re an analytical chemist and you basically specialize in finding stuff and by stuff, I mean small molecules and where they come from. And if I understand correctly, you have developed a test that can detect multiple viruses, including variants from a single sample and better yet. This can be done in a portable lab for remote testing. So has obvious implications for the era that we’re in right now, which is sort of coming out of the coronavirus . But first of all, did I get that completely wrong? Cause you know, I got my degrees in international relations, which should scare you. So tell us what this test does, how it works and why it matters. Dr. Timothy Garrett: 2:30 You got it almost a hundred percent correct. So good job. It’s a test that basically allows you to look at saliva, right? Isolate out instead of small molecules, isolate out proteins that are specific to individual viruses and that includes individual variants as well. And then allow you to measure those individual proteins in a portal style format. So basically in general, it’s a fairly simple process. We isolate the proteins and then we measure those proteins using mass spectrometry. And the cool part about the reason mass spec is important for this is it’s the, of the masses. Meaning that how much the proteins way allows us to really distinguish which protein it is and which virus it comes from. And that includes SARS coronavirus and the original one, as well as SARS cov two. And in Florida, we care about mosquito borne illnesses like Dengue and Zika and other ones. And it allows us also to see those unique patterns that allows us to really differentiate, which is which, and so the really cool part is that from that simple saliva sample, we’ll be able to diagnose what virus the person is infected with. And that would then allow us to really start treatment very much quicker rather than waiting for PCR, which would really only capture one specific virus at a time rather than what we could do is really just search the library and find out what’s there. Richard Miles : 3:38 So if I get this correct, Tim is the standard of care. Now that in order to really identify whether someone’s got virus A or B or C or D do they have to have blood drawn and then that blood goes off to a lab and then that you get a result back a couple of days later, is that the current state of affairs or is a real breakthrough here, this one, the saliva test part of it rather than the blood. And is there a speed element involved ? Dr. Timothy Garrett: 4:00 So you can test primarily as nasal swabs or saliva. Most of it was done with nasal swabs until we started thinking about saliva better. One of the key parts with current diagnostics is the use of PCR, polymerase chain reaction methods that are designed to target one specific part of a virus to amplify that signal, to really give you a really strong response. That means that you’re limited to whichever piece of the DNA or RNA that you start with to amplify, which is very specific. And so you need multiple tests for that. The real aspect of this is basically being able to look at patterns. So using pattern recognition approaches to save this as one virus versus another. And that really equates to speed. So you can take 30 minutes to prepare the sample and be able to measure all the viruses versus what you might have to do in a normal clinical lab, which is conducted 30 to 40 to an hour long run to identify a single type of virus. Richard Miles : 4:50 If we compare this to say like a lot of people have done already, like the saliva based coronavirus tests, but in that example, right, if I think I’ve got coronavirus, I ordered a test , they analyze it. If I had another virus, would that test pick it up or not? Dr. Timothy Garrett: 5:04 No, it would . It would not. So if you, instead of having coronavirus had the Zika or Dengue Fever, it would not capture that. And those have similar symptoms in some ways, headache and runny noses and those kinds of similar clinical symptoms, but you wouldn’t know. Richard Miles : 5:19 So with your process, somebody could walk into the doctor’s say I feel lousy. I don’t know what I have. They take a saliva sample and then you could potentially look at a whole bunch of different potential virus. Dr. Timothy Garrett: 5:27 That’s correct. Yeah. And we’ve started small on purpose to build libraries in a small way, but then it would expand exponentially really. And the cool part about it is it because it’s a library of information it’s easily transmitted to individuals who have access to measuring in this way, which is part of the reason why it makes it very portable because it’s really just querying a new database of information. And that database then provides the diagnostics. Richard Miles : 5:50 So it’s really in that back analysis, the saliva, right ? Cause this is an Elizabeth Holmes type thing, right. Where you’re just taking one drop or something and saying, Oh, there are 87 different things wrong with you right? Dr. Timothy Garrett: 6:01 Definitely not that, glad that you brought that up. That’s one of the biggest concerns with developing a test is following that route. But we look at small steps to make sure it works, with just one virus at a time. Right. And then once you do that, then you say, okay, now we can keep building upon that. And eventually, yeah, you could do hundreds maybe, but that would be way down the road. This sort of translates what we do for bacteriology right now in the clinical world for bacterial identification, we use similar approaches to measure patterns, to help us understand which bacteria you might have an infection. And so that’s running a sample and searching against the database to say, yes, we think you have this infection versus this one. Richard Miles : 6:35 Excuse me, for asking basic questions. But is there any difference from a practical standpoint or an analytical standpoint when you’re working with saliva versus blood? I mean, imagine working with slides a lot easier, right? Probably the way you handle it and care for it and store it is I’m guessing magnitudes easier than handling blood. But in terms of the information that you get from saliva, are you just as good or is it one notch down from what you could get from blood available? Dr. Timothy Garrett: 6:59 Saliva is just as good. And I had the same feeling you had initially when we started working with saliva, that it should be easier. But in fact, it’s 10 times harder. Richard Miles : 7:06 Really ok, shows you what I know. Dr. Timothy Garrett: 7:09 I didn’t either as an analytical chemist, it’s sort of a fairly new medium for me, blood we know a lot about, and we have a lot of processes in place to deal with how to process it and how to get rid of different components. Saliva has higher variability from individual to individual, meaning that how much water you drink might affect the concentration of saliva. It has so many enzymes that are designed to break down food that those enzymes can get in the way of measuring other species that , that aren’t enzymes like viruses that are present. And it still has the same infectious capability as blood does. And so if you get contact with saliva with viruses , so could have possibility of getting an infection. So from a perspective of trying to measure species that are in really, really low concentrations, the amount of other stuff present, causes a problem, Oh, and the other thing in our saliva, we have bacteria, right? The normal bacteria that live in a part of our gums in our mouth that are part of a healthy, as well as unhealthy mouth that are also confounding some of these issues. So you have sort of like a weird experiment that happens in our mouth every day when we eat. Richard Miles : 8:08 But from a patient perspective, it’s much easier obviously, right? Because nobody’s faints from giving a vial of saliva where a lot of people are still nervous and myself included about getting their blood drawn. They really don’t like it. So at least from the patient, it’s probably better. Dr. Timothy Garrett: 8:21 That’s a hundred percent true and it is easier to collect, right? Cause someone could collect a sample and drop it off rather than having to have a blood draw a thousand times much easier for individuals. And you can even send them a kit. Richard Miles : 8:31 They sent it to you in the mail and then they just walk you through it online. Exactly what to do. There’s obviously been a lot of attention the last year on fighting the coronavirus and almost exactly a year later, even as we’re doing this interview about roughly 20% of the population, a little bit less has received at least one shot. And it’s amazing. That is, I think some people have missed the breakthrough or maybe don’t fully understand in the underlying technology of messenger RNA as a process to make the vaccine and what that could mean in treating other diseases. I know that’s not exactly your field, but is that as big a deal as I’ve read or is that just hype? Dr. Timothy Garrett: 9:07 It is a big deal. Not only because of the speed at which it was developed, but the technology that’s in there and it opens up the idea of changing how we do vaccines in the future, right? So normally we have a live virus, right? That’s how you get the flu. The live virus has given you give a little bit of it that tells your body to react to the flu. And then when you get a real stimulus of the flu, you’re immune to that, that’s has some issues, right? In terms of growing it in terms of giving it to individuals, this one tricks your body in the same way to have an immune response, but uses messenger RNA as that trick. Right? And so now you can think about developing a flu virus. That’s not a live attenuated flu virus that could be used to in the same manner and then follow the same procedures and also potentially being a lot broader spectrum coverage then we get with the current life virus where we have to guess, which is going to be the biggest outbreak this year. So to me, as a scientist, looking at it, people worry about the speed of development. They have to sort of understand that all of that speed, we still went through all of the same clinical trials. It just went a lot faster because we had the money upfront to get people in the trials and do this trial as much faster than it would normally take. But the science behind it to me is exciting. And the next four to five years and how this is used is going to be another phase of neurology. Richard Miles : 10:16 Right. And if I understand it basically with the messenger RNA, you can basically trick or command your body, whatever verb you want to use into producing almost any protein that you want it to produce to fight off or handle a lot of different types of pathologies or diseases. And that is what has got researchers super excited. Yeah . Dr. Timothy Garrett: 10:32 Yeah. Some of the concerns was keeping it stable, right. And that’s the only real concern right now is making sure that it doesn’t fall apart or degrade, which is why you have to keep it that cold temperatures, but we’re going to solve that and Johnson and Johnson’s one came out and that somewhat solves that issue without worrying about cold storage. But yeah, and it’s tricking your body using a way to really hone in on a specific response is really intriguing. How we then grow from here is something, I think the scientific community is really gonna learn a lot from in this phase, but also in controlling other viruses. Richard Miles : 11:02 Yeah. As bad as this year has been for coronavirus . And certainly other people that have died has been a tragedy. Ironically, historians may look back on 2020, 2021 as making this huge breakthrough in treating, not just coronavirus, but other types of diseases and viruses that even five years ago or 10 years ago, if we’d been talking about trying to develop a vaccine inside of basically a year, less than a year or 10 months, that just would have been on the level almost of scifi . Dr. Timothy Garrett: 11:26 Exactly. And then also scaling it up and then manufacturing, not just developing but manufacturing yet at a high enough level to get people, even if we’re at 20%. Now we really only started vaccinating people in late December, January, right? Richard Miles : 11:38 The first few weeks is pretty chaotic if not incompetent. And so really a ton of the vaccination have taken place and probably the last four weeks or four to five weeks. Dr. Timothy Garrett: 11:46 Exactly. And you’ve mentioned something about the scientific part of it to me as a scientist, when the world sort of stuff went on different lockdowns, depending on what state you were in, the scientific community , started digging through the science really fast. We had some more time on our hands because we couldn’t sit in our labs and do experiments. So we started looking back at old papers that maybe we had to study before. And so what we saw then after that two month hiatus was after that you saw an explosion of scientific discovery, which to me was really fascinating to see. And if you look at the bio archives where people publish early work, you can sort of see how many COVID related publications came out from people who aren’t even studying viruses in the past that sort of got interested in thinking about a problem in a new way. So the scientific discovery, I think from this is one of the very interesting things to see, and then what comes all through this and what generation of scientists tackle this in a different way . Richard Miles : 12:34 That’s a great point. So let’s move from science to the world of business, like a fair number of researchers you’ve taken several of your technologies or research that you’ve done informed several companies and every story is different. So let’s hear yours, what, or who gave you the idea of commercializing some of the technologies and how are these companies doing? Dr. Timothy Garrett: 12:54 Commercializing really comes from me within and from other people that I’ve learned from the idea of taking something that you develop as a scientist and then write a paper on, but then also deciding how can we help communities with this? How can we design something that not only has good scientific background, but also can be implemented somewhere that helps us grow it as a community. Part of that, of course, the Cade. Robert Cade was a key part to see a scientist who’s working at the University of Florida, right? Developing a product that then becomes something that people really use and need in many different ways, whether there’s a , for normal healthcare , but also just for sports management. So seeing another scientist go that route is a way that I’ve really enjoyed trying to solve the right problems in a way that balances being an academic, but also trying to be an entrepreneur. And so with this new company that we’re in is only a couple of years old. It’s still growing as a company with not just the virus. In fact, we didn’t start it as a virus based company. It started as an analytical testing company for metabolomic measurements and performance, right? Measuring performance enhancement and understanding that how we can improve individual’s recovery and those kinds of components that go into management of athletes. And then when we couldn’t do that research for a little while, we moved on to thinking in new ways and how we could use the knowledge of the company to help and the virus space. And my background is a scientist. Richard Miles : 14:08 So Tim, sometimes as you well know, the world of basic research and academia is quite different than the world of startups and entrepreneurs and venture capital firms and so on. How did you negotiate that transition? And what do you notice in terms of those two different universes? Dr. Timothy Garrett: 14:23 So speed is one of the first things academic research is fairly slow and partly because you have to find funding right through different areas. And so you ended up having a much slower pace. And when you switched to a corporate or company based work, do you have to be much faster in terms of implementing something and coming up with a solution faster and you can’t necessarily do that without compromising sort of the science behind it. So part of it is making sure you have the right funding in place fast enough to hire the right people, to help those right problems, putting my academic hat on. It’s harder to make that fast paced translation for me. And so relying on others that we have in the company to help move that at the right pace is really what I’ve found to be the most beneficial part. Because training me is sort of like training a dog, a new trick, right? It takes a lot longer to train something new. You don’t end up keeping your old tricks. So really finding new people is one of the key benefits to me. Richard Miles : 15:13 The Cade Prize competition, we talk to a lot of folks who have done exactly what you’re doing in terms of moving their technologies to market. And several them have commented that the first shock was mostly in academia. And I know I’m generalizing here, but particularly in research, you work on research for a long time. You make a breakthrough, you publish it. You might go to a couple of conferences and talk about research and people applaud and go great job. And then you’re off to the next research, right? You’re sort of done, you’ve published your paper. And they’re shock was when they take this to market and investors go, yeah, that’s a great idea, but who’s going to buy it. Who’s going to pay for it. How fast can you produce it? So they all acknowledged the idea is great and that’s not really the benchmark anymore. Good idea versus bad idea. It’s good idea that can also be manufactured and sold. And that was a cold bath for some of these researchers. Who’ve never had to deal with that before. Dr. Timothy Garrett: 15:59 Yeah. And you’re sort of right. We do the research. We eventually published a paper on it and we talk about it. And then we think about the next research project. Can we sort of encapsulate that this is a publication from the work and go read it and we might often stop there versus yeah. The industry part is, okay, now this is a cool idea, but is there a market for it, right? Or is there protection for it, right. Maybe that maybe you don’t have protection. And we run in this space in biomarker discovery all the time. You find a new biomarker, they’re very difficult to protect. And so when you think about a company, you can still use a biomarker, but you might use it to develop the technology to measure that biomarker. And that would be then how you might translate a cut to make a company successful, putting that mindset on. It’s like, okay, this result has a high percentage of being successful in terms of diagnostic of patients. So how can we then translate that to making a product that works and that makes money and that also provides value to the community. Right? And so one of the hardest parts for me is really that part of taking that research idea and really thinking about what it would look like in the marketplace and not all of them will work that way. And you have to sort of bounce those ideas off of colleagues or friends or people that you think about to say, is there really, truly a market for this? And then find investors that might be interested in sort of helping you translate that to something that they might envision as a different route to it. So I like the publication part, but I also really like trying to see if it really will make a dent. And to me, healthcare is a big part. So healthcare. Richard Miles : 17:17 That’s what a lot of people say is it gratifying as a recognition is from colleagues in the academic world. It’s knowing that the technology, the research is actually helping people. And the only way that really happens is getting it to market right where it can help a bunch of people. And that’s really provides a lot of satisfaction, Dr. Timothy Garrett: 17:33 Right? And often our studies are on cells or on other kinds of systems and not on say human samples. And so really you have to see how it works testing in humans to understand really, will it have any impact in the same way that it has in normal laboratory setting . Richard Miles : 17:46 So Tim, at the beginning of the show, we talked about you did your undergraduate University of Georgia, but you actually spent your childhood in the Midwest and your dad also was a chemistry professor or a researcher and a lead scientist at Owen Corning’s fiberglass. But when you entered college, you told me you wanted to be an English major, but then chemistry found you. So first of all, what happened? And secondly, was there any evidence when you were a kid running around with four siblings, right. That you would be a top scientific researcher, did that just sort of come out of the blue? Dr. Timothy Garrett: 18:15 If you ask my siblings, there’s no evidence whatsoever. Richard Miles : 18:18 They’re still looking for it. Right. Dr. Timothy Garrett: 18:20 They’re looking for it. Yes. And I’m the youngest of four. I’m a twin though. So I’m the youngest by three minutes. And so as a kid, I struggled in the beginning with math. I didn’t do great about in middle school. I didn’t really come into understanding what I was really good at it until college. So I sort of was just a normal high school kid, did the normal stuff and I have good grades here and there. I did like science and I knew stuff for my dad. I got to visit his company and see sort of stuff he did, but I didn’t really quite understand it. And so you’re right. That chemistry really did find me. And the only reason is because I had to take chemistry because at Georgia, I was in college of liberal arts and sciences. And so I have to have a scientific program. So I was like, Nope, chemistry. I’ll take that. I can ask my dad any questions if I don’t understand them. And then I took it and I really enjoyed it. I didn’t think I would enjoy it. So then I had to take another general chemistry. So I took that and then I still was an English major or thinking about being English, which doesn’t make any sense to me nowadays. But then it made a lot of sense, but I do like reading and I do like writing, but it really wasn’t until I took organic chemistry. And a lot of people will tell you that organic chemistry is sort of cutoff points for both people, whether you like it or not. And so I took organic chemistry and I loved it. I could visualize the molecules in my head. I could really make connections that I didn’t think I could ever see before. And so it really was connecting what was on paper, putting that three-dimensional figure in your head of a molecule coming together or the shape of a symbol , like cyclohexane ring, whatever. And that part was so fascinating to me that you could then see what it looks like, but then also make reactions happen. Right. And then make products from that. And then the last part was doing research in college. Right. And then figuring out like it take one a, the size of a needle, a sample type, measuring what’s in that. And you can measure what was in that. If you just look at your pencil for a second, that’s smaller than that we can measure. Right. And that’s the , wow. You can really measure that amount of material and come up with an answer was pretty fascinating. Richard Miles : 20:08 I’m guessing that your dad was quite pleased, right? His , his kid goes off to college to be an English major and comes back as a chemistry researcher. Right. He must have been quite happy about that. Dr. Timothy Garrett: 20:17 He was happy, but he kept pushing me into polymer chemistry because that’s what he did. And so he wanted me to go that route cause he didn’t really quite understand what I could do with analytical chemistry right away. But definitely he was encouraging a hundred percent of the way. And I learned a lot about how to do science or how to think about science from him and got to sort of bounce ideas off of him because he could understand what I was trying to go through in grad school and trying to understand different parts of it. He could really help me think through scientific discovery and because of his background, even though it wasn’t the same field, he still sort of had that training and knowledge to help a lot on the way. Richard Miles : 20:48 Right. Well, it’s funny you had the opposite experience that I did. I was actually fairly good at math in high school. And then I got to college. I took my first advanced calculus class and just completely wiped me out. And I said to hell with that, I’m doing international relations. So, but , um, but my daughter became a math major. So it skipped a generation. So maybe your kids will be English majors Tim, theres still hope. Dr. Timothy Garrett: 21:07 There’s hope that they could be there. That’s that would be awesome. Yes. I totally support them whatever they like to do. Richard Miles : 21:12 So Tim, you also told me earlier that research is hard and that experiments don’t always work out. And one fascinating thing is you said, what you have found at least is at rest is really important. So can you expand a little bit about that? Because I get lots of rest. But I’m not working on any pathbreaking technology. So I feel like I’m doing something wrong. So what is your secret? Dr. Timothy Garrett: 21:31 Well, we sometimes get stuck thinking the same way all the time. I’m thinking about the problem , the same way all the time, because we either have our mindset that this is the way I’ve done it in the past. And it always works this way. And I continue to do that and we reach a part in research when you don’t know what the next experiment is, or you don’t know what the result means. If you keep trying to plug away and trying to just run experiment after experiment, you’re not going to necessarily come up with the answer. Right. But I look at it as is, you have to forget about it . And the reason you have to kind of forget about it is if you read a science fiction novel, or if you read something unrelated to your field, that you might get this ding that comes off that says, wow, that’s cool. And think about it in a different perspective. It’s like, well, I’ve been thinking about it this way for the last six months. What if I just do this? And you might just get a clear mind and my wife is an artist, right? And so part of that comes from seeing an artist think and seeing how an artist takes a lot of time and energy to go through many things in their head draws, sketches, and then trying to really balance between science and art to me has been part of that rest. Right? So turning off my scientific mind and just thinking non scientifically for awhile helps me think about new ways. And that then might be the next experiment that you designed, that you could then write it out on a napkin because then all of a sudden you think this would be a cool experiment to do, and I need to do it. And then you still have the knowledge to know how to do the experiment, but you’re just started from a different perspective. Richard Miles : 22:47 I understand that rest of you is a relative term. You have a young kids at home and a creative, energetic wife who I feel your pain. She’s usually volunteering you to do things to him that maybe you don’t want to do, but you’ve got to do them anyway. But it’s interesting what you say because a lot of brain researchers have said that there’s creative sparks come in fact, when we do relax our brains , so to speak and we take our hyper-focus off of our, our subject area and we stand back a little bit. And then like you said, as an artist maybe stands back from their painting, they’re able to see something there that they didn’t see before. So you’re definitely onto something. Dr. Timothy Garrett: 23:18 Yeah. I’m and to me it’s been the most beneficial parts are just taking a walk right outside and just looking at nature and not really contemplating anything, except it’s talking with a friend or just looking at the birds or here in Florida, looking at the alligators and then you see something or it reminds calm enough to see through the problem. And I think that calming part is really what we sort of miss. Sometimes this high stress high speed environment, you have to have a calming force to really put pieces together. And I deal with data sets that have thousands to hundreds of thousands of features, right. Or signals. And we have to try and make sense of those and that you can’t physically do that without having a relaxed kind of approach to it. Richard Miles : 23:57 Very well said, Tim, and really have enjoyed having you on the show, wish you the best of luck with your research and also your companies. And look forward to having you back for an update. Dr. Timothy Garrett: 24:06 Thank you very much for being a part of this. This is a great thing, and I’m glad that we could spend the time together talking. Richard Miles : 24:11 Great. Thanks Tim. Outro: 24:13 Radio Cade is produced by the Cade Museum for Creativity and Invention located in Gainesville, Florida. Richard Miles is the podcast host and Ellie Thom coordinates inventor interviews, podcasts are recorded at Heartwood Soundstage and edited and mixed by Bob McPeak . The Radio Cade theme song was produced and performed by Tracy Collins and features violinist Jacob Lawson.

Making virus testing easy, or at least easier, will enable companies and organizations to reopen faster as we enter the beginning of the post-corona era. Dr. Timothy Garrett, the Chief of Experimental Pathology at the University of Florida, has developed a test that can detect multiple viruses, including variants, from a single sample. Better yet, this can be done in a portable lab for remote testing, potentially making it widely available in many communities. 

This week we’re joined by Virologist Dr Ria Lina who’s ALSO a multi-awared winning comedian. She’s fearless, provocative and very funny. She’s unique in being the only female Filipina comedian in British stand up, she also has a BSc in Experimental Pathology, a MSc in Forensic Science and a PhD in Virology under her belt; so it’s not only her comedy that is highly intelligent. A regular contributor on Sky News and Talk Radio for her intellectual and comedic insight, Ria can also be seen on Mock The Week (BBC Two) in December 2020, with more big projects in the pipeline for 2021. We bombarded her with questions about a Covid Christmas, tiers, vaccines, students coming home, Track & Trace - all the questions a midlife person might haveMore about Dr Ria Lina. Website: https://rialina.com. https://www.tiktok.com/@rialinaofficial. On Twitter: https://twitter.com/rialina_. On Facebook: https://www.facebook.com/rialina/. On YouTube: https://www.youtube.com/rialinaMore about Aimee Cooper:. Instagram: @aimeecooperforms More about Louise Daniels: . Instagram: @louisedanielsofficial. Twitter: @LouiseDaniels_ https://producerpaul.co.uk See acast.com/privacy for privacy and opt-out information.

In this episode, Anand Padmanabhan, M.B.B.S., Ph.D., a physician-scientist and consultant in the divisions of Hematopathology, Transfusion Medicine, and Experimental Pathology at Mayo Clinic, discusses new ways to detect heparin-induced thrombocytopenia antibodies.

Why You Should Listen: In this episode, you will learn about deuterium and its impact on our health. About My Guest: My guest for this episode is Dr. T. Que Collins. T. Que Collins, PhD, MA, MS is a leading scientist when it comes to developing and applying nutrition and metabolic therapies to treat cancer in people and pets. He holds a PhD in Clinical Immunology, an MS in Oncotherapeutics, an MA in Experimental Pathology, and a BS in Poverty Health Care and Cancer Epidemiology. He is the Co-Founder and Principal Investigator at Cignature Health Metabolic Clinic now known as the Center for Deuterium Depletion. This is the first clinic in the world to use deuterium and tracer technologies to describe and follow the health status of patients with metabolic disorders such as cancer, diabetes, and autoimmune disorders. He is the Principal Investigator at Epigenix Foundation. This not-for-profit organization created by the founders of Quest Nutrition promotes research to prevent and ameliorate disease, maximize quality of life, and improve personal performance. He is also the Co-Founder and Principal Investigator at Ketopet Sanctuary. The sanctuary is a 53-acre ranch outside Austin, Texas that uses the ketogenic diet and other metabolic therapies with and without standard of care to treat dogs with naturally occurring cancers. Key Takeaways: - What are hydrogen and deuterium? - What symptoms and conditions are associated with elevated deuterium? - Does deuterium create an environment that is hospitable to pathogens? - What is deuterium depletion the basis of all functional medicine? - What is the D-TERMINATOR testing, and what does it reveal? - What functions in the body improve as deuterium is depleted? - Does drinking water increase deuterium levels? - What is the best type of water to drink? - Can deuterium depleted water be made at home? - What is the role of hydrogen water in a deuterium depletion discussion? - What foods increase and decrease deuterium levels? - Why is a higher fat diet helpful in depleting deuterium? - Do supplements have high levels of deuterium? - How might photobiomodulation support depletion of deuterium? - Do specific breathing exercises have a role in a deuterium depletion protocol? - Once deuterium levels are depleted, is a maintenance protocol needed? Connect With My Guest: http://DDCenters.com Interview Date: April 14, 2020 Transcript: To review a transcript of this show, visit http://BetterHealthGuy.com/Episode117 Additional Information: To learn more, visit http://BetterHealthGuy.com. Disclaimer: The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority.

COMMENTS AND FEEDBACK? GuerillaAspies@Outlook.comMother of three, Scientist, award winning comedian, actor and producer. Dr Ria Lina is one unique autistic person. Funny too.Of German and Phillipino ancestry, growing up in the UK, the USA and the Netherlands.Ria has a BSc in Experimental Pathology, an MSc in Forensic Science, and a PhD in Viral Bioinformatics. She worked as an IT Forensic Investigator for the Serious Fraud Office too, so don't try anything funny online with her.Ria is a winner of the EMMA (Ethnic Multicultural Media Academy) award, She is known for her television appearances in The World Stands Up, Mega Mela Malai Comedy and Sweet n Sour on BBC3. She has been an Edinburgh Festival regular which is how come we could discuss the Free Fringe and the people we mention. Tricity is a friend of ours and a brilliant performer in her own right, who kind of brought us together (It was her Bluestockings Cabaret we were both doing things upon. Oooer..)SUBSCRIBE TO RIA'S PODCAST - RIA LINA'S BEHIND ON ITUNES AND EVERYWHERE.I see Ria as yet another example of how autistic people, once diagnosed and immersed into the greater Autistic media and metaphorical Neurodiversity Movement, become clearly defined in their opinions and politics about everything NeuroDivergent. It seems to be an organic thing.COMMENTS AND FEEDBACK? GuerillaAspies@outlook.comSupport this show http://supporter.acast.com/guerilla-aspies-autism-aspergers-syndrome-neurodiversity. Hosted on Acast. See acast.com/privacy for more information.

Andrew and Theo chat with Comedian Ria Lina who is a comedian, actress, writer, and a winner of the EMMA award. She is known for her television appearances in The World Stands Up, Mega Mela Malai Comedy and Sweet n Sour on BBC3. Prior to her career as a comic, Lina acquired a BSc in Experimental Pathology, an MSc in Forensic Science, and a PhD in viral bioinformatics and worked as an IT Forensic Investigator for the Serious fraud Office.Of course Theo and Andrew also diverge on to many other topics with Ria including sweets and our recent UFO podcast special. Stick to the end and you'll hear Theo attempt to crack off a couple of 'jokes'. Watch, Listen and SUBSCRIBE on...YoutubePeriscopeTwitterStitcherFacebookI-TunesSoundcloud@VialucciMediaRecorded in London.Audio & Visual Production by Kerem Isik. Hosted on Acast. See acast.com/privacy for more information.

Steve Tepper and Carol Davis come onto the show to talk about reduction in variation and the flipped classroom model in healthcare education including where DPT programs stand as a whole on this, why these issues exist, pros and cons of flipped classroom and reduction in variation along with the evidence regarding this and Steve talks about Rehab Essentials and how it is contributing to improving healthcare education and reduction in variation in DPT education. Rehab Essentials Website: https://www.rehabessentials.com/  Rehab Essentials Facebook Page: https://www.facebook.com/RehabEssentials/  Rehab Essentials LinkedIn Page: https://www.linkedin.com/company/rehab-essentials-inc/  Rehab Essentials YouTube Page: https://www.youtube.com/channel/UCTdPlKsJrb2oHu-6zhTucgQ    Patient Practitioner Interaction (6th Edition) by Carol Davis: https://www.amazon.com/Patient-Practitioner-Interaction-Experiential-Developing/dp/1630910465/ref=pd_sbs_14_1?_encoding=UTF8&pd_rd_i=1630910465&pd_rd_r=7QHJRYKGKE04BB12MN69&pd_rd_w=ozYDC&pd_rd_wg=He4Nw&psc=1&refRID=7QHJRYKGKE04BB12MN69&dpID=41yH0XA1OUL&preST=_SY344_BO1,204,203,200_QL70_&dpSrc=detail    The PT Hustle Website: https://www.thepthustle.com/  Schedule an Appointment with Kyle Rice: www.passtheptboards.com    HET LITE Tool: www.pteducator.com/het     Research References Beaudoin, M. F. (2013). Institutional leadership. In M. G. Moore (Ed.), Handbook of distance education (pp. 467–480). London: Routledge.   Diaz, V., & Strickland, J. (2009). ELI discovery tool: Blended learning workshop guide. Educause Learning Initiative, Unit 7. Retrievedfrom https://library.educause.edu/resources/2009/11/eli-discovery-tool-blended-learning-workshop-guide   Garrison, D. R., & Kanuka, H. (2004). Blended learning: Uncovering its transformative potential in higher education. The Internet and Higher Education, 7(2), 95–105.https://doi.org/10.1016/j.iheduc.2004.02.001   Graham, C. R. (2013). Emerging practice and research in blended learning. In M. G. Moore (Ed.), Handbook of Distance Education (3rd ed., pp. 333–350). New York, NY: Routledge.   Joosten, T. M., Barth, D., Harness, L., & Weber, N. L. (2013). The impact of instructional development and blended teaching on course effectiveness. In A. G. Picciano, C. D. Dziuban, & C. R. Graham (Eds.), Blended Learning: Research Perspectives (Vol. 2, pp. 173–189). New York, NY: Routledge.   King, S., & Arnold, K. C. (2012). Blended learning environments in higher education: a case study of how professors make it happen. Mid-Western Educational Researcher,25(1/2), 44–59.   Moisei, S. D., & Hughes, J. A. (2008). Supporting the online learner. In T. Anderson (Ed.), The theory and practice of online learning (2nd ed., pp. 419–439). Athabasca University Press. Retrieved from http://www.aupress.ca/index.php/books/120146 (Links to an external site.)   Picciano, A. G. (2009). Blending with purpose: The multimodal model. Journal of Asynchronous Learning Networks, 13(1).   Watson, J. (2008). Promising practices in online learning: Blended learning – the convergence of online and face-to-face education. North American Council for Online Learning. Retrieved from https://eric.ed.gov/?id=ED509636   Biographies: Steven H. Tepper, PT, PhD, FAPTA is President of Rehab Essentials, Inc., which powers the transitional DPT program at University of Montana.  He is also a “freelance” professor with the Universities of Delaware, George Washington, Maryland, the Ohio State, & Virginia Commonwealth. Dr. Tepper received his BS in Physical Therapy and a PhD in Experimental Pathology from the University of Maryland.  He taught at University of Maryland for 12 years and then spent 13 years Shenandoah University where he was a full professor and Director of the entry-level and transitional-DPT programs. He has authored several chapters and peer reviewed journal articles on various topics.  His professional highlights include President of the Cardiovascular and Pulmonary Section of the APTA, Task Force Member on Clinical Practice Guidelines III for the APTA, recipient of the Cardiovascular and Pulmonary Sections Linda Crane Merit Award 1999, University of Maryland Alumnus of the Year 2003, Robert C. Bartlett Award for Innovation in Fundraising from the Foundation for Physical Therapy 2005, the Lucy Blair Service Award recipient, 2013, Charles Magistro Service Award from the Foundation for PT and became Catherine Worthingham Fellow in 2016.  Dr. Tepper has a passion for teaching.   Carol M. Davis, DPT, EdD, MS, FAPTA is  Professor Emerita and immediate past Vice Chair of the Department of Physical Therapy at the University of Miami Miller School of Medicine in Miami, Florida.    She is also a clinician in active clinical practice, primarily treating patients with cervical and lumbar spine pain utilizing energy-based manual therapy, myofascial release, along with exercise.   Dr. Davis is an international lecturer and consultant and a respected author in rehabilitation literature.  She is the author/editor of 4 editions of texts: Integrative Therapies in Rehabilitation – Evidence for Efficacy in Therapy, Prevention and Wellness, as well as 6 editions of Patient-Practitioner Interaction – an Experiential Manual for Developing the Art of Health Care, both published by Slack Books, Inc., and several text book chapters, many focusing on the science of energy medicine and complementary therapies.  She has published over 30 articles in peer reviewed journals. Her areas of scholarly interest include educating students and professionals in the affective domain, particularly in professional interactions in health care, ethics, empathy, using the self as a therapeutic presence with patients, along with her clinical scholarship of investigating sustained release myofascial release as a manual therapy to assist in reducing pain and restoring cellular health.   Dr. Davis has traveled to several countries as a consultant in these two main areas of her interest, and has received many honors. In 2017 she was awarded the national Outstanding Mentor Award by Women in Academic Medicine in San Francisco. She was recognized in Canada as the first Helen Saarinen Lecturer at McMaster University, in Hong Kong as a visiting Academic Scholar, and in the United States by Utica College, Syracuse University as Distinguished Faculty Lecturer of the Year, and by the American Physical Therapy Association with the Dorothy Briggs Memorial Scientific  Inquiry Award, the Lucy Blair Service Award, the Geriatric Section Distinguished Faculty Educator Award, The Cardiopulmonary Section Linda

Georgina Ferry interviews Gordon MacPherson. Gordon MacPherson retired as Reader in Experimental Pathology at the Dunn School in 2008, having spent almost his entire scientific career in the department. He first came to Oxford in the early 1960s to read medicine, where he heard lectures by the newly-appointed head of the Dunn School Henry Harris, and learned practical skills from Margaret Jennings (Lady Florey). He completed his medical training at the London Hospital in Whitechapel, before returning to pursue a DPhil in the Dunn School with John French on blood platelets. At Harris’s suggestion, he then took up a fellowship at the John Curtin Medical School in Canberra to train in immunology, and after his return established a group that was one of the first to characterise dendritic cells, key regulators of the immune response. He has subsequently led explored a wide range of interactions involving dendritic cells, such as how they transport the prion particles that cause diseases such as scrapie in sheep and Creutzfeldt-Jakob disease in humans. Alongside his research, MacPherson is widely admired for his skills as a teacher and lecturer. He is co-author, with Jon Austyn, of Exploring Immunology: Concepts and Evidence, a concise textbook for undergraduates published in 2012.

My guest is Dr. Fergus Couch who is, among many other roles, Professor and Chair of the Division of Experimental Pathology and Laboratory Medicine at the Mayo Clinic. Dr. Couch works on the genetics of breast cancer, discovering and understanding the connections of inherited genetic variance in cancer susceptibility genes. He's also a BCRF Grand Tee since 2007. Dr. Couch has more than 300 publications, but the one we focused on came just a few months ago and it was an incredibly big deal. The outcomes were published in the prestigious publications Nature and Nature Genetics. Dr. Fergus and other scientists reported findings by a major international consortium identifying an incredible 65 previously unknown common genetic variants that predisposed individuals to breast cancer. They also found seven others that are specific for triple negative breast cancer, the highly aggressive forms of the disease. In all, that's 72 new genetic variants that contribute to breast cancer risk. The numbers that drove the research are remarkable. Over 500 researchers, from 300 institutions, in six continents contributed genetic data from some 275,000 women, 146,000 of whom had been diagnosed with breast cancer.    

Ria is a British comedian, actress, and writer, and a winner of the EMMA. She is known for her television appearances in The World Stands Up and Sweet n Sour on BBC3 amongst others. Prior to her career as a comic, Lina acquired a BSc in Experimental Pathology, an MSc in Forensic Science, and a PhD in Viral Bioinformatics and worked as an IT Forensic Investigator for the Serious Fraud Office. The boys were introduced to Ria by previous guest Jordan Gray, (check out Jordans epic episode a few weeks back, Top 5 comedians, alive and working), and were very keen to get her on to do a top 5. You have seen the title. Yes its epic. Yes its weird. Its rude and explicit and its a once you get turned on to researching, it can kills hours of fun laughing at others mis-fortune.This two parter is a barn burner, Ria was very funny, settled right into Chris and Stu's usual mumblingand we get to find out a lot about Stu's taste in movies and his shady sexual deviances. See acast.com/privacy for privacy and opt-out information.

Ria is a British comedian, actress, and writer, and a winner of the EMMA. She is known for her television appearances in The World Stands Up and Sweet n Sour on BBC3 amongst others. Prior to her career as a comic, Lina acquired a BSc in Experimental Pathology, an MSc in Forensic Science, and a PhD in Viral Bioinformatics and worked as an IT Forensic Investigator for the Serious Fraud Office. The boys were introduced to Ria by previous guest Jordan Gray, (check out Jordans epic episode a few weeks back, Top 5 comedians, alive and working), and were very keen to get her on to do a top 5. You have seen the title. Yes its epic. Yes its weird. Its rude and explicit and its a once you get turned on to researching, it can kills hours of fun laughing at others mis-fortune.This two parter is a barn burner, Ria was very funny, settled right into Chris and Stu's usual mumblingand we get to find out a lot about Stu's taste in movies and his shady sexual deviances. See acast.com/privacy for privacy and opt-out information.

Dr Eric Sidebottom, Retired University Lecturer in Experimental Pathology, gives a lunch time talk to accompany the exhibition 'Great Medical Discoveries: 800 Years of Oxford Innovation'.

Dr Eric Sidebottom, Retired University Lecturer in Experimental Pathology, gives a lunch time talk to accompany the exhibition 'Great Medical Discoveries: 800 Years of Oxford Innovation'.

Regenerative Medicine Today welcomes Andrew Duncan, PhD. Dr. Duncan is an assistant professor in the Department of Pathology, Division of Experimental Pathology.  Dr. Duncan discusses his research in liver development, homeostasis, and regeneration. For more information about Dr. Duncan, click here. Host John Murphy. For more information about the McGowan Institute for Regenerative Medicine, visit: McGowan Institute Research [...]

Mauro Pistello, Department of Experimental Pathology, Retrovirus Center and Virology Section, University of Pisa, Italy speaks on "What feline immunodeficiency virus can teach us about HIV". This seminar has been recorded by ICGEB Trieste